DONALDSON Co INC acquires Purilogics, LLC
Snapshot
DONALDSON Co INC acquired Purilogics, LLC for approximately $19.9 million (net of cash acquired); up to $29.0 million additional contingent consideration in June 2022. The transaction was structured as all cash plus contingent consideration. Purilogics, LLC is a Headquartered in Greenville, South Carolina-based Life Sciences business.
- Acquirer
- DONALDSON Co INC
- Target
- Purilogics, LLC
- Value
- approximately $19.9 million (net of cash acquired); up to $29.0 million additional contingent consideration
- Date
- June 2022
- Type
- Full acquisition
- Status
- Ready
The deal at a glance
DONALDSON Co INC acquired Purilogics, LLC for approximately $19.9 million (net of cash acquired); up to $29.0 million additional contingent consideration, a transaction completed in June 2022, structured as all cash plus contingent consideration.
Purilogics, LLC operates in Life Sciences, is based in Headquartered in Greenville, South Carolina. Purilogics is an early-stage biotechnology company that developed proprietary Purexa membrane chromatography products for the purification and streamlined manufacturing of biopharmaceuticals. Aimed initially at the purification of pDNA, mRNA and mAbs, the Purexa membrane platform offers competitive advantages over traditional resin and monolith technologies, enabling improved productivity, speed and production costs.
Adds membrane chromatography purification technology to Donaldson's bioprocessing portfolio.
Up to $29.0 million contingent consideration tied to developing manufacturing capabilities, creating future technologies and attaining business performance results. Life Sciences segment
No advisory firms have been disclosed for this transaction.